Susan Mahony

Susan Mahony currently works at Zymeworks BC, Inc., as Director from 2019, Axsome Therapeutics, Inc., as Independent Director from 2023, Assembly Biosciences, Inc., as Independent Director from 2017, Park Tudor School, as Director from 2015, Cereius, Inc., as Director, Chordoma Foundation, as Director, Altis Biosystems, Inc., as Director, Kovina Therapeutics, Inc., as Director from 2021, Zymeworks, Inc., as Lead Independent Director, and Catalent, Inc., as Director.
Dr. Mahony also formerly worked at Horizon Therapeutics Ltd. (Ireland), as Independent Director, United Way of Central Indiana, Inc., as Director from 2010 to 2012, Corden Pharma Fribourg SA, as Director from 2019 to 2022, Vifor Pharma Management AG, as Director from 2019 to 2022, Amgen, Inc., as Principal from 1991 to 1995, Bristol Myers Squibb Co., as Principal from 1995 to 2000, Eli Lilly & Co., as Senior Vice President from 2011 to 2018, Schering-Plough Corp., as Principal from 1989 to 1991, Eli Lilly Canada, Inc., as President & General Manager, and Lilly Oncology, as President & Senior Vice President from 2011 to 2018.
Dr. Mahony received her undergraduate degree and doctorate degree from the University of Aston and Masters Business Admin degree in 1998 from London Business School.